Korean Ginseng
Panax ginseng · Extract (Korean Ginseng) 0.6-2.0 g root
Korean Ginseng (Panax ginseng) is a nutraceutical permitted for use in nutraceuticals and health supplements under India's FSSAI framework, with a permitted limit of 90-400 mg/day max. Regulyze tracks its regulatory status, limits and label requirements across regulatory frameworks.
Regulatory status
| Framework | Status | Limit | Source | Last reviewed |
|---|---|---|---|---|
| India — FSSAI | Permitted | 90-400 mg/day max | FSS (Health Supplements, Nutraceuticals…) Regulations 2022 | 2026-06-20 |
Coverage for the USA (FDA), EU (EFSA), UK, GCC and ASEAN is being added — this page updates automatically as frameworks are assessed.
About Korean Ginseng
Korean Ginseng is tracked in the Regulyze Ingredient Intelligence database as a nutraceutical (Panax ginseng). The regulatory details on this page are generated from Regulyze's structured regulatory dataset and are reviewed against the cited source.
Frequently asked questions
Is Korean Ginseng permitted in nutraceuticals under FSSAI (India)?
Korean Ginseng (Panax ginseng) (listed in the regulation as “Panax ginseng extract (Korean Ginseng) 0.6-2.0 g root”) is currently permitted for use in health supplements and nutraceuticals under India's FSSAI framework, per FSS (Health Supplements, Nutraceuticals…) Regulations 2022. Always verify against the current official regulation for your product and market.
What is the permitted dosage of Korean Ginseng?
The permitted level recorded for Korean Ginseng is 90-400 mg/day max. Limits can vary by product type and market — confirm against the current regulation.
What product category does Korean Ginseng belong to?
Korean Ginseng is classified under: Nutraceuticals, Botanicals.
What is the botanical (scientific) name of Korean Ginseng?
Korean Ginseng corresponds to Panax ginseng, with the extract (korean ginseng) 0.6-2.0 g root used in nutraceutical preparations.
Source: FSS (Health Supplements, Nutraceuticals…) Regulations 2022 · Last reviewed: 2026-06-20 · Data version: db-2026-06-20. Indicative only — verify against the current official regulation before use.
Regulyze